Evidence map›Paper›PMID 42305149›Full record

ArticleMycology2026

Metabologenomic profiling of the endemic Australian fungus

Amr A Arishi, Nirmal K Chaudhary, John A Kalaitzis, Daniel Vuong, Andrew Crombie, Cameron L M Gilchrist, Ernest Lacey, Peter Karuso, Andrew M Piggott, Yit-Heng Chooi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mycology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amr A ArishiSchool of Molecular Sciences, The University of Western Australia, Perth, Australia.ORCID https://orcid.org/0000-0001-5158-7559
Nirmal K ChaudharySchool of Natural Sciences, Macquarie University, Sydney, Australia.ORCID https://orcid.org/0000-0001-5801-2483
John A KalaitzisSchool of Natural Sciences, Macquarie University, Sydney, Australia.ORCID https://orcid.org/0000-0001-9647-7652
Daniel VuongMicrobial Screening Technologies Pty Ltd., Smithfield, Australia.ORCID https://orcid.org/0000-0002-2451-3148
Andrew CrombieMicrobial Screening Technologies Pty Ltd., Smithfield, Australia.
Cameron L M GilchristSchool of Molecular Sciences, The University of Western Australia, Perth, Australia.ORCID https://orcid.org/0000-0001-7798-427X
Ernest LaceySchool of Natural Sciences, Macquarie University, Sydney, Australia.ORCID https://orcid.org/0000-0002-5387-2721
Peter KarusoDepartment of Applied Biosciences, Macquarie University, Sydney, Australia.ORCID https://orcid.org/0000-0002-0217-6021
Andrew M PiggottSchool of Natural Sciences, Macquarie University, Sydney, Australia.ORCID https://orcid.org/0000-0002-5308-5314
Yit-Heng ChooiSchool of Molecular Sciences, The University of Western Australia, Perth, Australia.ORCID https://orcid.org/0000-0001-7719-7524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel and rare fungal species continue to serve as an invaluable source of new natural products. In this study, we conducted a comprehensive metabologenomic assessment of the endemic Australian fungus

Indexed as

Aspergillus luteorubrusbiosynthesisbiosynthetic geneschemodiversityfungiSecondary metabolites

Identifiers

PMID42305149
PMCPMC13267043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.